1.The usefulness of color Doppler ultrasound in diagnosing venous diseases of lower extremity: a comparison with DSA
Yamei ZHANG ; Shuzhi WANG ; Jianping GU ; Songwang CHEN ; Yan HUANG
Journal of Interventional Radiology 2009;18(12):904-907
Objective To evaluate the color Doppler ultrasound in diagnosing venous diseases of lower extremity, and to compare it with DSA. Methods By using color Doppler ultrasound (CDUS)apparatus, two-dimensional spectrum, color Doppler flow image, pulse wave Doppler and Valsalva examination were performed in 48 patients with suspected venous diseases of lower extremity. The CDUS findings were compared with DSA findings. Results Of 48 cases with suspected lower extremity venous diseases, deep vein thrombosis formation was confirmed in 27, among them 15 were accompanied with lower extremity deep venous valvular incompetence, 8 were complicated by lower extremity varicosity and 2 were associated with both conditions. Another one had cyst in the left popliteal fossa and popliteal venous thrombosis. Decreased blood flow in iliac veins was found in some cases. Pure lower extremity venous valvular incompetence was seen in 5 cases and pure lower extremity superficial varicosity in 6 cases. Six cases suffered both valvular incompetence and superficial varicosity. CDUS showed normal findings in 4 cases, of them DSA demonstrated compressed iliac vein in 2. When taking DSA as golden standard, the accuracy of CDUS was 95.83%. By using the uniformity test, Kappa value was 0.65. Conclusion CDUS is of great clinical usefulness in diagnosing venous diseases of lower extremity as well as in evaluating the therapeutic effect.
2.The Current Status of Informatization Construction and Application in Provincial Disease Prevention and Control Institutions
Songwang WANG ; Yujie MENG ; Yanfei LI ; Qiang CHEN ; Rui ZHANG ; Xiaopeng QI
Journal of Medical Informatics 2017;38(7):46-50
The paper issues questionnaires to investigate the current status of informatization construction and application in 32 provincial disease prevention and control institutions of China,summarizes the current status of informatization organization and management,standard planning,capital input and allocation,analyzes the problems existing in the process of disease control informatization construction,focuses on the discussion of imbalanced regional development,insufficient capital input,lack of informatization personnel,and lack of informatization security awareness,and proposes corresponding suggestions and countermeasures.
3.Comparison of ablation effect of Nd:YAG laser with different power and energy based on ultrasound guidance.
Songwang CHEN ; Dahua XU ; Jianping GU
Chinese Journal of Medical Instrumentation 2013;37(1):57-61
To explore the optimum laser power and energy in porcine thyroid ablation in vitro with 1 064 nm Nd:YAG laser of different power and energy guided by ultrasound after comparison of size and pathology of ablation lesions. The experimental results showed that Laser ablation effect of porcine thyroid in vitro is definite, the size of ablation lesions increases as the laser power and energy increases, when the laser power and energy are 3 W and 1 800 J, the ablation lesion effect reaches ideal level.
Animals
;
Laser Therapy
;
instrumentation
;
methods
;
Lasers, Solid-State
;
Swine
;
Thyroid Gland
;
diagnostic imaging
;
surgery
;
Ultrasonography
4.Inhibitory effect of small interference RNA targeting hypoxia-inducible factor 1 alpha nanospheres on human esophageal squamous carcinoma TE-1 cell growth
Hongying LIAO ; Jiangping SONG ; Lijia GU ; Yimin WENG ; Yun LI ; Jian ZHANG ; Songwang CAI ; Chao YU ; Huiguo CHEN ; Cuiping WANG
Chinese Journal of Tissue Engineering Research 2009;13(38):7493-7497
BACKGROUND: Nanosphere, an ideal nonviral gene delivery vector, is not excellence of immunogenicity and oncogenicity. Nanotechnology and gene interference are used to block hypoxia-inducible factor 1 alpha (HIF-1α) expression in esophageal squamous carcinoma tissue and decrease tolerance of malignant cells to chemotherapeutics. Theoretically, they become effective methods to inhibit malignant cell growth of esophageal squamous carcinoma. OBJECTIVE: To study the inhibitory effect of small interference RNA targeting HIF-1α (siRNA-HIF-1α) nanospheres on human esophageal squamous cancer TE-1 cell growth. DESIGN, TIME AND SETTING: Based on in vitro cultured esophageal squamous cancer TE-1 cells, a completely randomized controlled study was performed at the Central Laboratory, the Third Hospital Affiliated to Sun Yat-sen University from January 2007 to December 2008. MATERIALS: siRNA-HIF-1α was synthesized by Shanghai Bioengineering Company; siRNA-HIF-1α nanospheres were prepared using solvent evaporation technique; human esophageal squamous cancer TE cell strain was provided by Shanghai Cell Bank of the Chinese Academy of Sciences. METHODS: TE-1 cells cultured in vitro were assigned into four groups: saline, gene-free nanospheres, siRNA-HIF-1α, and siRNA-HIF-1α nanospheres groups. MAIN OUTCOME MEASURES: HIF-1α mRNA expression was detected by RT-PCR; HIF-1α protein expression was detected by Western blot; apoptosis of TE-1 cells was determined by flow cytometry; TE-1 cell growth was examined by MTT. RESULTS: At 72 hours after treatment, both HIF-1α mRNA expression and HIF-1α protein expression in the siRNA-HIF-1α nanospheres group were significantly less than other three groups (P < 0.01), but apoptotic rate was significantly greater than other three groups (P < 0.01). TE-1 cell growth was remarkably inhibited in the siRNA-HIF-1α nanospheres group, which was significantly different compared with other three groups (P < 0.01).CONCLUSION: siRNA-HIF-1α nanospheres can specifically reduce both HIF-1α mRNA and HIF-1α protein expressions in esophageal squamous carcinoma TE-1 cells, significantly increase tumor cell apoptosis, and remarkably inhibit TE-1 cell growth.
5.Ultrasound-guided para-aneurysmal saline injection for the treatment of iatrogenic femoral pseudoaneurysm: preliminary results in 18 patients
Yun ZHOU ; Songwang CHEN ; Yan HUANG ; Jinhua SONG ; Jianping GU
Journal of Interventional Radiology 2018;27(2):163-166
Objective To assess the clinical value of ultrasound-guided para-aneurysmal saline injection (PASI) in the treatment of iatrogenic femoral pseudoaneurysm, i.e. postcatheterization femoral artery pseudoaneurysm (FAP). Methods A total of 18 patients developed FAP after receiving interventional therapy through femoral artery puncturing, the diagnosis was confirmed by clinical and color ultrasonography examinations in all patients. Under real-time color Doppler ultrasound guidance and ECG monitoring, PASI was carried out. Local anesthesia was performed by injection of 5-10 ml of 1% lidocaine, which was followed by percutaneous puncturing with a 21-gauge needle, that was connected to a plastic syringe filled with 0.9% sodium chloride solution, into the site about 2-5mm away from the fistula between the pseudoaneurysm and the formal artery, then, the saline was continuously and slowly injected into this area until the abnormal blood flow signal within the fistula disappeared. Manual compression was applied on the local area for about 5 minutes. The dose of injected saline and the total time of the procedure were recorded. Clinical and color Doppler ultrasound reexaminations were conducted at 24 hours, one week and one month after the treatment, and the local pulsation, murmur, intra-pseudoaneurysmal blood flow and thrombosis were tested. Results Successful treatment with single procedure was achieved in 17 patients (17/18, 94.4%). In one patient continuous blood flow signal within the pseudoaneurysm was still observed at 24 hours after PASI, and successful closure of the pseudoaneurysm was obtained after the second time of PASI. The time of the procedure was 14-30 min, with a mean of (19.2±8.0) min. The injection volume of saline was 40-150 mL, with a mean of (67.2±29.3) mL. The treatment process could be well tolerated by all patients, only one patient developed transient bradycardia due to vagus reflex. Postoperative 30-day follow-up examination showed that no recurrent blood flow was detected within the pseudoaneurysm, no complications such as venous thrombosis, limb ischemia or local infection were observed, and the pseudoaneurysmal hematoma was completely absorbed. Conclusion For the treatment of postcatheterization FAP, ultrasound-guided PASI is technically-simple and clinically-safe with low medical cost, besides, this therapy can be well tolerated by patients. Therefore, PASI is worthy of clinical application.
6.GLUL stabilizes N-Cadherin by antagonizing β-Catenin to inhibit the progresses of gastric cancer.
Qiwei JIANG ; Yong LI ; Songwang CAI ; Xingyuan SHI ; Yang YANG ; Zihao XING ; Zhenjie HE ; Shengte WANG ; Yubin SU ; Meiwan CHEN ; Zhesheng CHEN ; Zhi SHI
Acta Pharmaceutica Sinica B 2024;14(2):698-711
Glutamate-ammonia ligase (GLUL, also known as glutamine synthetase) is a crucial enzyme that catalyzes ammonium and glutamate into glutamine in the ATP-dependent condensation. Although GLUL plays a critical role in multiple cancers, the expression and function of GLUL in gastric cancer remain unclear. In the present study, we have found that the expression level of GLUL was significantly lower in gastric cancer tissues compared with adjacent normal tissues, and correlated with N stage and TNM stage, and low GLUL expression predicted poor survival for gastric cancer patients. Knockdown of GLUL promoted the growth, migration, invasion and metastasis of gastric cancer cells in vitro and in vivo, and vice versa, which was independent of its enzyme activity. Mechanistically, GLUL competed with β-Catenin to bind to N-Cadherin, increased the stability of N-Cadherin and decreased the stability of β-Catenin by alerting their ubiquitination. Furthermore, there were lower N-Cadherin and higher β-Catenin expression levels in gastric cancer tissues compared with adjacent normal tissues. GLUL protein expression was correlated with that of N-Cadherin, and could be the independent prognostic factor in gastric cancer. Our findings reveal that GLUL stabilizes N-Cadherin by antagonizing β-Catenin to inhibit the progress of gastric cancer.